{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:52:57Z","timestamp":1793393577755,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.autrev.2014.08.013","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T19:08:14Z","timestamp":1408734494000},"page":"1203-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":255,"title":["The clinical spectrum of IgG4-related disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.autrev.2014.08.013_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-RD","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.013_bb0010","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.013_bb0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.013_bb0020","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-RD and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.013_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-RD","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semdp.2012.08.002","article-title":"IgG4-RD: nomenclature, clinical features, and treatment","volume":"29","author":"Stone","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.013_bb0035","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-RD","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.autrev.2014.08.013_bb0040","doi-asserted-by":"crossref","first-page":"358371","DOI":"10.1155\/2012\/358371","article-title":"Prevalence of IgG4-RD in Japan based on nationwide survey in 2009","volume":"2012","author":"Uchida","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.013_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00535-011-0465-z","article-title":"Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification","volume":"47","author":"Nakazawa","year":"2012","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2014.08.013_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2012.01.007","article-title":"The immunobiology and clinical characteristics of IgG4 related diseases","volume":"39","author":"Takahashi","year":"2012","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2014.08.013_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000090033","article-title":"IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy","volume":"6","author":"Kamisawa","year":"2006","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.013_bb0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2169\/internalmedicine.49.3038","article-title":"Metachronous extrapancreatic lesions in autoimmune pancreatitis","volume":"49","author":"Takuma","year":"2010","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.013_bb0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/02841851003738846","article-title":"Renal lesions associated with autoimmune pancreatitis: CT findings","volume":"51","author":"Triantopoulou","year":"2010","journal-title":"Acta Radiol"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.013_bb0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.dld.2011.03.006","article-title":"Characteristics of autoimmune pancreatitis based on serum IgG4 level","volume":"43","author":"Matsubayashi","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.013_bb0080","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.013_bb0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5009\/gnl.2013.7.1.96","article-title":"Clinical characteristics of patients with autoimmune pancreatitis with or without Mikulicz's disease and Mikulicz's disease alone","volume":"7","author":"Kuruma","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.autrev.2014.08.013_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-230X-13-168","article-title":"IgG4 related disease \u2014 a retrospective descriptive study highlighting Canadian experiences in diagnosis and management","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.013_bb0095","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1440-1746.2010.06411.x","article-title":"Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma","volume":"25","author":"Oh","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.013_bb0100","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.013_bb0105","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/jgh.12248","article-title":"Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort","volume":"28","author":"Ohara","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.013_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jhbp.50","article-title":"Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan","volume":"21","author":"Tanaka","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.013_bb0115","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00330-014-3127-8","article-title":"Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors","volume":"24","author":"You","year":"2014","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.013_bb0120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.pas.0000164031.59940.fc","article-title":"Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (K\u00fcttner's tumor)","volume":"29","author":"Kitagawa","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.013_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e3181c811ad","article-title":"Chronic sclerosing sialadenitis (K\u00fcttner tumor) is an IgG4-associated disease","volume":"34","author":"Geyer","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/rheumatology\/kes358","article-title":"Necessity of early intervention for IgG4-related disease\u2014delayed treatment induces fibrosis progression","volume":"52","author":"Shimizu","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/lary.22449","article-title":"Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis","volume":"122","author":"Ohta","year":"2012","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.013_bb0140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7863\/ultra.32.5.731","article-title":"Localized or diffuse lesions of the submandibular glands in immunoglobulin g4-related disease in association with differential organ involvement","volume":"32","author":"Asai","year":"2013","journal-title":"J Ultrasound Med"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.013_bb0145","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00784-012-0905-z","article-title":"Clinical characteristics of Mikulicz's disease as an IgG4-related disease","volume":"17","author":"Moriyama","year":"2013","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.autrev.2014.08.013_bb0150","doi-asserted-by":"crossref","DOI":"10.3109\/14397595.2013.853336","article-title":"Evaluation of submandibular versus labial salivary gland fibrosis in IgG4-related disease","author":"Takano","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.013_bb0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","article-title":"Ocular adnexal IgG4-related disease has uniform clinicopathology","volume":"58","author":"Sato","year":"2008","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.013_bb0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archophthalmol.2010.45","article-title":"Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder","volume":"128","author":"Kubota","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.013_bb0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2559.2011.04089.x","article-title":"Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions","volume":"60","author":"Go","year":"2012","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bjophthalmol-2012-302857","article-title":"Ocular adnexal IgG4-related disease: CT and MRI findings","volume":"97","author":"Song","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0175","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00417-013-2541-y","article-title":"Clinical features of IgG4-related dacryoadenitis","volume":"252","author":"Koizumi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00417-013-2548-4","article-title":"Location and frequency of lesions in patients with IgG4-related ophthalmic diseases","volume":"252","author":"Sogabe","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.013_bb0185","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.013_bb0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2511080965","article-title":"Immunoglobulin G4-related lung disease: CT findings with pathologic correlations","volume":"251","author":"Inoue","year":"2009","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0195","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/resp.12016","article-title":"Immunoglobulin G4-related lung disease: clinicoradiological and pathological features","volume":"18","author":"Matsui","year":"2013","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.013_bb0200","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.013_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.013_bb0210","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3174\/ajnr.A3147","article-title":"MR imaging of IgG4-related disease in the head and neck and brain","volume":"33","author":"Toyoda","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.013_bb0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/03009742.2013.822094","article-title":"IgG4-related disease in a Chinese cohort: a prospective study","volume":"43","author":"Chen","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.013_bb0220","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-related tubulointerstitial nephritis","volume":"22","author":"Raissian","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0225","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.humpath.2011.06.002","article-title":"Characteristic tubulointerstitial nephritis in IgG4-related disease","volume":"43","author":"Yamaguchi","year":"2012","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.013_bb0230","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/ndt\/gfr761","article-title":"Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis","volume":"27","author":"Yoshita","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0235","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ki.2013.191","article-title":"The clinical course of patients with IgG4-related kidney disease","volume":"84","author":"Saeki","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.013_bb0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","article-title":"Rethinking Ormond's disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease","volume":"92","author":"Khosroshahi","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.013_bb0245","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anndiagpath.2013.03.004","article-title":"Interstitial cystitis: another IgG4-related inflammatory disease?","volume":"17","author":"Crumley","year":"2013","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0250","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/modpathol.2011.177","article-title":"Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells","volume":"25","author":"Grimm","year":"2012","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.013_bb0255","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/modpathol.2012.54","article-title":"Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes","volume":"25","author":"Sato","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.013_bb0260","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.anndiagpath.2013.04.010","article-title":"IgG4-related disease-like fibrosis as an indicator of IgG4-related lymphadenopathy","volume":"17","author":"Uehara","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.autrev.2014.08.013_bb0265","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment","author":"Lu","year":"2014","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0270","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2009-1794","article-title":"Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells","volume":"95","author":"Li","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03009742.2012.761281","article-title":"Clinical features of a new disease concept, IgG4-related thyroiditis","volume":"42","author":"Watanabe","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.013_bb0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.013_bb0285","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.urology.2013.10.052","article-title":"Immunoglobulin G4-related prostatitis: a case\u2013control study focusing on clinical and pathologic characteristics","volume":"83","author":"Buijs","year":"2014","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.013_bb0290","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/PAS.0b013e3181998cbe","article-title":"IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases","volume":"33","author":"Cheuk","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.013_bb0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00428-010-0995-4","article-title":"Paratesticular fibrous pseudotumor\u2014an IgG4-related disorder?","volume":"458","author":"B\u00f6sm\u00fcller","year":"2011","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.013_bb0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.013_bb0305","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/00016489.2010.533699","article-title":"IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease","volume":"131","author":"Moteki","year":"2011","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0310","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/lary.23792","article-title":"Nasal manifestations of immunoglobulin G4-related disease","volume":"123","author":"Suzuki","year":"2013","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.013_bb0315","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0003489414526844","article-title":"Otologic manifestations of immunoglobulin G4-related disease","volume":"123","author":"Takagi","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.013_bb0320","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/modpathol.2012.196","article-title":"Clinicopathologic analysis of IgG4-related skin disease","volume":"26","author":"Sato","year":"2013","journal-title":"Mod Pathol"},{"issue":"35","key":"10.1016\/j.autrev.2014.08.013_bb0325","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.3748\/wjg.v19.i35.5769","article-title":"Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases?","volume":"19","author":"Koizumi","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.013_bb0330","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.autrev.2014.01.010","article-title":"Diagnosis and classification of autoimmune pancreatitis","volume":"13","author":"Okazaki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.08.013_bb0335","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/BOR.0b013e32834ddb4a","article-title":"The latest on IgG4-RD: A rapidly emerging disease","volume":"24","author":"Carruthers","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.013_bb0340","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2014.01.040","article-title":"Diagnosis and classification of primary sclerosing cholangitis","volume":"13","author":"Yimam","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.013_bb0345","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","article-title":"Diagnostic criteria of autoimmune hepatitis","volume":"13","author":"Liberal","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T06:55:33Z","timestamp":1538290533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1568997214001578"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.013","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical spectrum of IgG4-related disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}